These are called Holter monitors and they are essentially ambulatory ECG devices that monitor the heart. Such monitors can ...

Bayer has decided to discontinue a phase 3 trial of its oral Factor XIa inhibitor asundexian in patients with atrial fibrillation (AF), after an interim analysis concluded the novel anticoagulant ...

Tester Kristin Currin-Sheehan was drawn to Google Pixel for its Atrial Fibrillation (AFib) tracking using Electrocardiogram (ECG) technology, after experiencing heart and lung-related health ...